Skip to content

Effect of Xuefu Zhuyu Capsule on chest pain after thoracoscopic surgery for early non-small cell lung cancer

Effect of Xuefu Zhuyu Capsule on chest pain after thoracoscopic surgery for early non-small cell lung cancer

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100005319
Enrollment
Unknown
Registered
2021-09-17
Start date
2021-09-20
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

NSCLC

Interventions

Xuefu Zhuyu Capsule group:Xuefu Zhuyu Capsule

Sponsors

Peking University People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) Patients who underwent thoracoscopic lobectomy, lobectomy, compound lobectomy or total lobectomy with or without mediastinal lymph node resection; (2) Postoperative pathological diagnosis was primary non-small cell lung cancer stage I, ? a or carcinoma in situ; (3) There was no chest pain before operation, but within 3 months after operation; (4) They were 18-85 years old; (5) Willing to participate in clinical trials, signed informed consent, and can contact follow-up Only those who meet all the above conditions can be included in the study

Exclusion criteria

Exclusion criteria: (1) Lung secondary malignant tumor patients; (2) Patients with severe primary diseases such as heart, brain, kidney; (3) Psychotic patients; (4) Those who meet the diagnostic criteria of non-small cell lung cancer but have undergone surgery, radiotherapy, chemotherapy, targeted therapy and received traditional Chinese medicine treatment in recent 3 months; Those who met any of the above criteria could not be included in this study

Design outcomes

Primary

MeasureTime frame
Effective rate of pain improvement;Quality of life score;Cough score;TCM syndrome integral;

Countries

China

Contacts

Public ContactMeng Yufeng
1173809106@qq.com18810901822

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026